Atria Wealth Solutions Inc. Has $1.31 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Atria Wealth Solutions Inc. boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,548 shares of the exchange traded fund’s stock after buying an additional 2,822 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,310,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC lifted its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC boosted its position in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $40,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth $49,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $91.70 on Monday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The stock has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average of $91.36 and a 200-day moving average of $96.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.